Anti-TPO Antibodies: biomarker evidence

Anti-TPO Antibodies appears in 1 entry of the OSMF biomarker atlas, covering Hypothyroidism. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Hypothyroidism

Where Anti-TPO Antibodies is reported

Also listed as: Anti-TPO

ConditionDirectionCompared againstAssociated symptomsSource
Hypothyroidism↑ elevatedautoimmune (Hashimoto's) hypothyroidism patients vs healthy reference—Kondramashin et al. 2021

Frequently asked questions

In which conditions is Anti-TPO Antibodies altered?

In the OSMF atlas Anti-TPO Antibodies is reported in Hypothyroidism. It is elevated in 1 across 1 entries.

Is there a standard clinical test for Anti-TPO Antibodies?

The atlas entries for Anti-TPO Antibodies do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Anti-TPO Antibodies result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Anti-TPO Antibodies across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/anti-tpo-antibodies.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-07-03 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.